9960.HK

Kindstar Global (Beijing) Technology, Inc. [9960.HK] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

9960.HK Stock Summary

Top 10 Correlated ETFs

9960.HK

Top 10 Correlated Stocks

9960.HK

In the News

9960.HK Financial details

Company Rating
-
Market Cap
1.49B
Income
56.9M
Revenue
1.22B
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
3.13K
Optionable
No
Shortable
Yes
Earnings
04 Mar 2024
P/E
16.51
Forward P/E
-
PEG
-1.61
P/S
1.13
P/B
0.44
P/C
-
P/FCF
-15.28
Quick Ratio
2.32
Current Ratio
3.19
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
0.07
EPS next Y
-
EPS next Q
-
EPS this Y
-103.24%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
NAN%
Revenue last 5Y
14.45%
Revenue Q/Q
-
EPS Q/Q
-
-
-
-
-
SMA20
-4.44%
SMA50
7.5%
SMA100
12.17%
Inst Own
-
Inst Trans
-
ROA
2%
ROE
3%
ROC
0.05%
Gross Margin
43%
Oper. Margin
10%
Profit Margin
5%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
1.38-1.98
52W High
+35%
52W Low
+35%
RSI
58.4
Rel Volume
0.14
Avg Volume
463.13K
Volume
64.5K
Perf Week
9.76%
Perf Month
-4.93%
Perf Quarter
12.5%
Perf Half Y
11.57%
-
-
-
-
Beta
0.794
-
-
Volatility
0.04%, 0.07%
Prev Close
0%
Price
1.35
Change
0.75%

Something similar

Top by Market Cap
DHR-PB
FXAIX
MSF.DE
AAPL
LLY.DE
Top Correlated ETFs
3086.HK
XAD6.MI
FCQH.TO
3097.HK
IWDL
Top Correlated Stocks
2348.HK
0393.HK
0598.HK
0856.HK
1086.HK
Similar Market Cap
INTA
RIIN.TO
PYVSX
CE2.DE
PCRX

Company Profile

Healthcare Medical - Care Facilities
  • Volume Average 463.13K
  • Market Capitalization 1.49B
  • Employee 3.13K
  • CEO Dr. Shiang Huang
  • Headquarters Wuhan,CN
  • IPO Date 2021-07-16
  • Website https://www.kindstar.com.cn/en/

Kindstar Global (Beijing) Technology, Inc. provides medical esoteric testing services to hospitals in China. Its services include medical research, drug trial, and translational medicine research services for physicians, medical science and technology institutions, specialty and general hospitals, and pharmaceutical companies. The company's lab platforms comprise flow cytometry, cytogenetic, medical genomics, molecular biology, hematopathology, mass spectrum, pathology, clinical immunology, microbiology, and scientific research laboratories. It provides tests in blood, tumor, and genetics; and cardiovascular, cerebrovascular, infectious, and autoimmune diseases, as well as in internal medicine, surgery, gynecology, pediatrics, and other specialties. The company was founded in 2003 and is headquartered in in Wuhan, China.